Organization Overview
Historical Acquisition Tree
Alternative names
margetuximab (Margenza) (2020)
Adenocarcinoma (Phase 1)
Breast Neoplasms (Phase 3)
Carcinoma (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Carcinoma, Renal Cell (Phase 1)
Carcinoma, Squamous Cell (Phase 3)
Colorectal Neoplasms (Phase 2)
Desmoplastic Small Round Cell Tumor (Phase 1)
Diabetes Mellitus (Phase 3)
Diabetes Mellitus, Type 1 (Phase 3)
Encephalitis (Phase 2)
Fever (Phase 2)
Head and Neck Neoplasms (Phase 1)
Hematologic Neoplasms (Phase 1)
Infections (Phase 2)
Lung Neoplasms (Phase 1)
Melanoma (Phase 1)
Meningitis (Phase 2)
Mesothelioma (Phase 1)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 2)
Neuroblastoma (Phase 1)
Osteosarcoma (Phase 1)
Pancreatic Neoplasms (Phase 2)
Paralysis (Phase 2)
Prostatic Neoplasms (Phase 1)
Psoriasis (Phase 2)
Rhabdomyosarcoma (Phase 1)
Sarcoma (Phase 1)
Sarcoma, Ewing (Phase 1)
Squamous Cell Carcinoma of Head and Neck (Phase 3)
Stomach Neoplasms (Phase 3)
Triple Negative Breast Neoplasms (Phase 1)
Urinary Bladder Neoplasms (Phase 1)
Virus Diseases (Phase 2)
West Nile Fever (Phase 2)
Wilms Tumor (Phase 1)